Caxton Associates (UK)’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Caxton Associates (UK)'s EXAS Position: Q1 2026 in Review
Caxton Associates (UK) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 331,682 shares — an estimated $33.7M sold.
Caxton Associates (UK) first reported a position in EXAS in Q3 2025 and held it in 2 quarters. The position peaked at $33.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Caxton Associates (UK) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 331,682 Exact Sciences shares in Q1 2026, an estimated $33.7M.
- Caxton Associates (UK) first reported a position in Exact Sciences in Q3 2025 and held it in 2 quarters.
- Caxton Associates (UK)'s Exact Sciences position peaked at $33.7M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.